Pfizer Short Interest Down 5.2% in April (PFE)
Shares of Pfizer (NYSE:PFE) were the recipient of a large drop in short interest in April. As of April 30th, there was short interest totalling 52,494,773 shares, a drop of 5.2% from the April 15th total of 55,395,129 shares, Analyst Ratings News reports. Currently, 0.8% of the shares of the stock are sold short. Based on an average daily volume of 32,409,762 shares, the days-to-cover ratio is presently 1.6 days.
PFE has been the subject of a number of recent research reports. Analysts at BMO Capital Markets cut their price target on shares of Pfizer from $36.00 to $34.00 in a research note on Tuesday, May 6th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Pfizer in a research note on Tuesday, May 6th. They now have a $31.00 price target on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Pfizer from $34.00 to $36.00 in a research note on Friday, May 2nd. They now have an “outperform” rating on the stock. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $32.76.
Pfizer (NYSE:PFE) opened at 29.49 on Monday. Pfizer has a 1-year low of $27.12 and a 1-year high of $32.96. The stock has a 50-day moving average of $30.25 and a 200-day moving average of $31.06. The company has a market cap of $188.1 billion and a price-to-earnings ratio of 9.21.
Pfizer (NYSE:PFE) last announced its earnings results on Monday, May 5th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.01. The company had revenue of $11.35 million for the quarter, compared to the consensus estimate of $12.07 billion. During the same quarter in the previous year, the company posted $0.54 earnings per share. The company’s revenue for the quarter was down 8.5% on a year-over-year basis. On average, analysts predict that Pfizer will post $2.24 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, June 3rd. Shareholders of record on Friday, May 9th will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 3.53%. The ex-dividend date of this dividend is Wednesday, May 7th.
Pfizer Inc (NYSE:PFE) is a research-based, global biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.